 | • レポートコード：MRC2102QY17060 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の徐放性眼用ドラッグデリバリーシステム市場について種類別（リポソーム、マイクロカプセル/ナノカプセル、ミクロスフェア/ナノスパー、インプラント）、用途別（白内障、緑内障、角膜移植、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・徐放性眼用ドラッグデリバリーシステム市場の概要 ・世界の主要地域別徐放性眼用ドラッグデリバリーシステム市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の徐放性眼用ドラッグデリバリーシステム市場規模2015-2026：種類別（リポソーム、マイクロカプセル/ナノカプセル、ミクロスフェア/ナノスパー、インプラント） ・世界の徐放性眼用ドラッグデリバリーシステム市場規模2015-2026：用途別（白内障、緑内障、角膜移植、その他） ・徐放性眼用ドラッグデリバリーシステムの米国市場規模2015-2020 ・徐放性眼用ドラッグデリバリーシステムのヨーロッパ市場規模2015-2020 ・徐放性眼用ドラッグデリバリーシステムの中国市場規模2015-2020 ・徐放性眼用ドラッグデリバリーシステムの日本市場規模2015-2020 ・徐放性眼用ドラッグデリバリーシステムの東南アジア市場規模2015-2020 ・徐放性眼用ドラッグデリバリーシステムのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・徐放性眼用ドラッグデリバリーシステムの製造コスト分析 ・販売チャネル、流通業者、顧客 ・徐放性眼用ドラッグデリバリーシステムの市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Sustained Release Ocular Drug Delivery Systems Market
The global Sustained Release Ocular Drug Delivery Systems market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Sustained Release Ocular Drug Delivery Systems Scope and Market Size
The global Sustained Release Ocular Drug Delivery Systems market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sustained Release Ocular Drug Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Sustained Release Ocular Drug Delivery Systems market is segmented into
Liposome
Microcapsules/Nanocapsules
Microspheres/Nanosptheres
Implants
Segment by Application, the Sustained Release Ocular Drug Delivery Systems market is segmented into
Cataract
Glaucoma
Corneal Transplantation
Others
The Sustained Release Ocular Drug Delivery Systems market is analysed and market size information is provided by regions (countries). Segment by Application, the Sustained Release Ocular Drug Delivery Systems market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Sustained Release Ocular Drug Delivery Systems Market Share Analysis
Sustained Release Ocular Drug Delivery Systems market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Sustained Release Ocular Drug Delivery Systems business, the date to enter into the Sustained Release Ocular Drug Delivery Systems market, Sustained Release Ocular Drug Delivery Systems product introduction, recent developments, etc.
The major vendors covered:
pSivida
Allergan
Icon Bioscience
Ocular Therapeutix
Neurotech Pharmaceuticals
Santen Pharmaceutical
Aciont Inc.
Envisia Therapeutics
GrayBug
Innocore Pharmaceuticals
OHR Pharmaceuticals
PolyActiva
TheraKine
1 Sustained Release Ocular Drug Delivery Systems Market Overview
1.1 Sustained Release Ocular Drug Delivery Systems Product Scope
1.2 Sustained Release Ocular Drug Delivery Systems Segment by Type
1.2.1 Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2020-2026)
1.2.2 Liposome
1.2.3 Microcapsules/Nanocapsules
1.2.4 Microspheres/Nanosptheres
1.2.5 Implants
1.3 Sustained Release Ocular Drug Delivery Systems Segment by Application
1.3.1 Global Sustained Release Ocular Drug Delivery Systems Sales Comparison by Application (2020-2026)
1.3.2 Cataract
1.3.3 Glaucoma
1.3.4 Corneal Transplantation
1.3.5 Others
1.4 Sustained Release Ocular Drug Delivery Systems Market Estimates and Forecasts (2015-2026)
1.4.1 Global Sustained Release Ocular Drug Delivery Systems Sales Growth Rate (2015-2026)
1.4.2 Global Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2015-2026)
1.4.3 Global Sustained Release Ocular Drug Delivery Systems Price Trends (2015-2026)
2 Sustained Release Ocular Drug Delivery Systems Estimate and Forecast by Region
2.1 Global Sustained Release Ocular Drug Delivery Systems Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Sustained Release Ocular Drug Delivery Systems Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2015-2020)
2.2.2 Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region (2015-2020)
2.3 Global Sustained Release Ocular Drug Delivery Systems Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Sustained Release Ocular Drug Delivery Systems Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Sustained Release Ocular Drug Delivery Systems Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Sustained Release Ocular Drug Delivery Systems Estimates and Projections (2015-2026)
2.4.2 Europe Sustained Release Ocular Drug Delivery Systems Estimates and Projections (2015-2026)
2.4.3 China Sustained Release Ocular Drug Delivery Systems Estimates and Projections (2015-2026)
2.4.4 Japan Sustained Release Ocular Drug Delivery Systems Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Sustained Release Ocular Drug Delivery Systems Estimates and Projections (2015-2026)
2.4.6 India Sustained Release Ocular Drug Delivery Systems Estimates and Projections (2015-2026)
3 Global Sustained Release Ocular Drug Delivery Systems Competition Landscape by Players
3.1 Global Top Sustained Release Ocular Drug Delivery Systems Players by Sales (2015-2020)
3.2 Global Top Sustained Release Ocular Drug Delivery Systems Players by Revenue (2015-2020)
3.3 Global Sustained Release Ocular Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sustained Release Ocular Drug Delivery Systems as of 2019)
3.4 Global Sustained Release Ocular Drug Delivery Systems Average Price by Company (2015-2020)
3.5 Manufacturers Sustained Release Ocular Drug Delivery Systems Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Sustained Release Ocular Drug Delivery Systems Players (Opinion Leaders)
4 Global Sustained Release Ocular Drug Delivery Systems Market Size by Type
4.1 Global Sustained Release Ocular Drug Delivery Systems Historic Market Review by Type (2015-2020)
4.1.1 Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2015-2020)
4.1.2 Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Type (2015-2020)
4.1.3 Global Sustained Release Ocular Drug Delivery Systems Price by Type (2015-2020)
4.2 Global Sustained Release Ocular Drug Delivery Systems Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Sustained Release Ocular Drug Delivery Systems Sales Forecast by Type (2021-2026)
4.2.2 Global Sustained Release Ocular Drug Delivery Systems Revenue Forecast by Type (2021-2026)
4.2.3 Global Sustained Release Ocular Drug Delivery Systems Price Forecast by Type (2021-2026)
5 Global Sustained Release Ocular Drug Delivery Systems Market Size by Application
5.1 Global Sustained Release Ocular Drug Delivery Systems Historic Market Review by Application (2015-2020)
5.1.1 Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2015-2020)
5.1.2 Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Application (2015-2020)
5.1.3 Global Sustained Release Ocular Drug Delivery Systems Price by Application (2015-2020)
5.2 Global Sustained Release Ocular Drug Delivery Systems Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Sustained Release Ocular Drug Delivery Systems Sales Forecast by Application (2021-2026)
5.2.2 Global Sustained Release Ocular Drug Delivery Systems Revenue Forecast by Application (2021-2026)
5.2.3 Global Sustained Release Ocular Drug Delivery Systems Price Forecast by Application (2021-2026)
6 United States Sustained Release Ocular Drug Delivery Systems Market Facts & Figures
6.1 United States Sustained Release Ocular Drug Delivery Systems Sales Market Share by Company (2015-2020)
6.2 United States Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2015-2020)
6.3 United States Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2015-2020)
7 Europe Sustained Release Ocular Drug Delivery Systems Market Facts & Figures
7.1 Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share by Company (2015-2020)
7.2 Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2015-2020)
7.3 Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2015-2020)
8 China Sustained Release Ocular Drug Delivery Systems Market Facts & Figures
8.1 China Sustained Release Ocular Drug Delivery Systems Sales Market Share by Company (2015-2020)
8.2 China Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2015-2020)
8.3 China Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2015-2020)
9 Japan Sustained Release Ocular Drug Delivery Systems Market Facts & Figures
9.1 Japan Sustained Release Ocular Drug Delivery Systems Sales Market Share by Company (3015-3030)
9.2 Japan Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2015-2020)
9.3 Japan Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2015-2020)
10 Southeast Asia Sustained Release Ocular Drug Delivery Systems Market Facts & Figures
10.1 Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2015-2020)
11 India Sustained Release Ocular Drug Delivery Systems Market Facts & Figures
11.1 India Sustained Release Ocular Drug Delivery Systems Sales Market Share by Company (2015-2020)
11.2 India Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2015-2020)
11.3 India Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Sustained Release Ocular Drug Delivery Systems Business
12.1 pSivida
12.1.1 pSivida Corporation Information
12.1.2 pSivida Business Overview
12.1.3 pSivida Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
12.1.4 pSivida Sustained Release Ocular Drug Delivery Systems Products Offered
12.1.5 pSivida Recent Development
12.2 Allergan
12.2.1 Allergan Corporation Information
12.2.2 Allergan Business Overview
12.2.3 Allergan Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Allergan Sustained Release Ocular Drug Delivery Systems Products Offered
12.2.5 Allergan Recent Development
12.3 Icon Bioscience
12.3.1 Icon Bioscience Corporation Information
12.3.2 Icon Bioscience Business Overview
12.3.3 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Products Offered
12.3.5 Icon Bioscience Recent Development
12.4 Ocular Therapeutix
12.4.1 Ocular Therapeutix Corporation Information
12.4.2 Ocular Therapeutix Business Overview
12.4.3 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Products Offered
12.4.5 Ocular Therapeutix Recent Development
12.5 Neurotech Pharmaceuticals
12.5.1 Neurotech Pharmaceuticals Corporation Information
12.5.2 Neurotech Pharmaceuticals Business Overview
12.5.3 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Products Offered
12.5.5 Neurotech Pharmaceuticals Recent Development
12.6 Santen Pharmaceutical
12.6.1 Santen Pharmaceutical Corporation Information
12.6.2 Santen Pharmaceutical Business Overview
12.6.3 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Products Offered
12.6.5 Santen Pharmaceutical Recent Development
12.7 Aciont Inc.
12.7.1 Aciont Inc. Corporation Information
12.7.2 Aciont Inc. Business Overview
12.7.3 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Products Offered
12.7.5 Aciont Inc. Recent Development
12.8 Envisia Therapeutics
12.8.1 Envisia Therapeutics Corporation Information
12.8.2 Envisia Therapeutics Business Overview
12.8.3 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Products Offered
12.8.5 Envisia Therapeutics Recent Development
12.9 GrayBug
12.9.1 GrayBug Corporation Information
12.9.2 GrayBug Business Overview
12.9.3 GrayBug Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
12.9.4 GrayBug Sustained Release Ocular Drug Delivery Systems Products Offered
12.9.5 GrayBug Recent Development
12.10 Innocore Pharmaceuticals
12.10.1 Innocore Pharmaceuticals Corporation Information
12.10.2 Innocore Pharmaceuticals Business Overview
12.10.3 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Products Offered
12.10.5 Innocore Pharmaceuticals Recent Development
12.11 OHR Pharmaceuticals
12.11.1 OHR Pharmaceuticals Corporation Information
12.11.2 OHR Pharmaceuticals Business Overview
12.11.3 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
12.11.4 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Products Offered
12.11.5 OHR Pharmaceuticals Recent Development
12.12 PolyActiva
12.12.1 PolyActiva Corporation Information
12.12.2 PolyActiva Business Overview
12.12.3 PolyActiva Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
12.12.4 PolyActiva Sustained Release Ocular Drug Delivery Systems Products Offered
12.12.5 PolyActiva Recent Development
12.13 TheraKine
12.13.1 TheraKine Corporation Information
12.13.2 TheraKine Business Overview
12.13.3 TheraKine Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
12.13.4 TheraKine Sustained Release Ocular Drug Delivery Systems Products Offered
12.13.5 TheraKine Recent Development
13 Sustained Release Ocular Drug Delivery Systems Manufacturing Cost Analysis
13.1 Sustained Release Ocular Drug Delivery Systems Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Sustained Release Ocular Drug Delivery Systems
13.4 Sustained Release Ocular Drug Delivery Systems Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Sustained Release Ocular Drug Delivery Systems Distributors List
14.3 Sustained Release Ocular Drug Delivery Systems Customers
15 Market Dynamics
15.1 Sustained Release Ocular Drug Delivery Systems Market Trends
15.2 Sustained Release Ocular Drug Delivery Systems Opportunities and Drivers
15.3 Sustained Release Ocular Drug Delivery Systems Market Challenges
15.4 Sustained Release Ocular Drug Delivery Systems Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Sustained Release Ocular Drug Delivery Systems Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Region (2015-2020)
Table 5. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2015-2020)
Table 6. Global Sustained Release Ocular Drug Delivery Systems Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Region (2015-2020)
Table 8. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Sustained Release Ocular Drug Delivery Systems Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Sustained Release Ocular Drug Delivery Systems Revenue Share Forecast by Region (2021-2026)
Table 12. Global Sustained Release Ocular Drug Delivery Systems (K Pcs) of Key Companies (2015-2020)
Table 13. Global Sustained Release Ocular Drug Delivery Systems Sales Share by Company (2015-2020)
Table 14. Global Sustained Release Ocular Drug Delivery Systems Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Company (2015-2020)
Table 16. Global Sustained Release Ocular Drug Delivery Systems by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sustained Release Ocular Drug Delivery Systems as of 2019)
Table 17. Global Sustained Release Ocular Drug Delivery Systems Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Sustained Release Ocular Drug Delivery Systems Manufacturing Sites and Area Served
Table 19. Manufacturers Sustained Release Ocular Drug Delivery Systems Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Sustained Release Ocular Drug Delivery Systems Players
Table 22. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Type (2015-2020)
Table 23. Global Sustained Release Ocular Drug Delivery Systems Sales Share by Type (2015-2020)
Table 24. Global Sustained Release Ocular Drug Delivery Systems Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Sustained Release Ocular Drug Delivery Systems Price (K Pcs) by Type (2015-2020)
Table 26. Global Sustained Release Ocular Drug Delivery Systems Sales Share by Type (2021-2026)
Table 27. Global Sustained Release Ocular Drug Delivery Systems Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Type (2021-2026)
Table 29. Global Sustained Release Ocular Drug Delivery Systems Price (K Pcs) by Type (2021-2026)
Table 30. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Application (2015-2020)
Table 31. Global Sustained Release Ocular Drug Delivery Systems Sales Share by Application (2015-2020)
Table 32. Global Sustained Release Ocular Drug Delivery Systems Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Sustained Release Ocular Drug Delivery Systems Price (K Pcs) by Application (2015-2020)
Table 34. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Application (2021-2026)
Table 35. Global Sustained Release Ocular Drug Delivery Systems Sales Share by Application (2021-2026)
Table 36. Global Sustained Release Ocular Drug Delivery Systems Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Application (2021-2026)
Table 38. Global Sustained Release Ocular Drug Delivery Systems Price (K Pcs) by Application (2021-2026)
Table 39. United States Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Company (2015-2020)
Table 40. United States Sustained Release Ocular Drug Delivery Systems Sales Market Share by Company (2015-2020)
Table 41. United States Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Type (2015-2020)
Table 42. United States Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2015-2020)
Table 43. United States Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Application (2015-2020)
Table 44. United States Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2015-2020)
Table 45. Europe Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share by Company (2015-2020)
Table 47. Europe Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2015-2020)
Table 49. Europe Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2015-2020)
Table 51. China Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Company (2015-2020)
Table 52. China Sustained Release Ocular Drug Delivery Systems Sales Market Share by Company (2015-2020)
Table 53. China Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Type (2015-2020)
Table 54. China Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2015-2020)
Table 55. China Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Application (2015-2020)
Table 56. China Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2015-2020)
Table 57. Japan Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Sustained Release Ocular Drug Delivery Systems Sales Market Share by Company (2015-2020)
Table 59. Japan Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2015-2020)
Table 61. Japan Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2015-2020)
Table 69. India Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Company (2015-2020)
Table 70. India Sustained Release Ocular Drug Delivery Systems Sales Market Share by Company (2015-2020)
Table 71. India Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Type (2015-2020)
Table 72. India Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2015-2020)
Table 73. India Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Application (2015-2020)
Table 74. India Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2015-2020)
Table 75. pSivida Corporation Information
Table 76. pSivida Description and Business Overview
Table 77. pSivida Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. pSivida Sustained Release Ocular Drug Delivery Systems Product
Table 79. pSivida Recent Development
Table 80. Allergan Corporation Information
Table 81. Allergan Description and Business Overview
Table 82. Allergan Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Allergan Sustained Release Ocular Drug Delivery Systems Product
Table 84. Allergan Recent Development
Table 85. Icon Bioscience Corporation Information
Table 86. Icon Bioscience Description and Business Overview
Table 87. Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Icon Bioscience Sustained Release Ocular Drug Delivery Systems Product
Table 89. Icon Bioscience Recent Development
Table 90. Ocular Therapeutix Corporation Information
Table 91. Ocular Therapeutix Description and Business Overview
Table 92. Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Product
Table 94. Ocular Therapeutix Recent Development
Table 95. Neurotech Pharmaceuticals Corporation Information
Table 96. Neurotech Pharmaceuticals Description and Business Overview
Table 97. Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product
Table 99. Neurotech Pharmaceuticals Recent Development
Table 100. Santen Pharmaceutical Corporation Information
Table 101. Santen Pharmaceutical Description and Business Overview
Table 102. Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Product
Table 104. Santen Pharmaceutical Recent Development
Table 105. Aciont Inc. Corporation Information
Table 106. Aciont Inc. Description and Business Overview
Table 107. Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Aciont Inc. Sustained Release Ocular Drug Delivery Systems Product
Table 109. Aciont Inc. Recent Development
Table 110. Envisia Therapeutics Corporation Information
Table 111. Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Envisia Therapeutics Description and Business Overview
Table 113. Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Product
Table 114. Envisia Therapeutics Recent Development
Table 115. GrayBug Corporation Information
Table 116. GrayBug Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. GrayBug Description and Business Overview
Table 118. GrayBug Sustained Release Ocular Drug Delivery Systems Product
Table 119. GrayBug Recent Development
Table 120. Innocore Pharmaceuticals Corporation Information
Table 121. Innocore Pharmaceuticals Description and Business Overview
Table 122. Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product
Table 124. Innocore Pharmaceuticals Recent Development
Table 125. OHR Pharmaceuticals Corporation Information
Table 126. OHR Pharmaceuticals Description and Business Overview
Table 127. OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product
Table 129. OHR Pharmaceuticals Recent Development
Table 130. PolyActiva Corporation Information
Table 131. PolyActiva Description and Business Overview
Table 132. PolyActiva Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 133. PolyActiva Sustained Release Ocular Drug Delivery Systems Product
Table 134. PolyActiva Recent Development
Table 135. TheraKine Corporation Information
Table 136. TheraKine Description and Business Overview
Table 137. TheraKine Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 138. TheraKine Sustained Release Ocular Drug Delivery Systems Product
Table 139. TheraKine Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Sustained Release Ocular Drug Delivery Systems Distributors List
Table 143. Sustained Release Ocular Drug Delivery Systems Customers List
Table 144. Sustained Release Ocular Drug Delivery Systems Market Key Trends
Table 145. Sustained Release Ocular Drug Delivery Systems Key Opportunities and Drivers
Table 146. Sustained Release Ocular Drug Delivery Systems Market Challenges
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Sustained Release Ocular Drug Delivery Systems Product Picture
Figure 2. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Sustained Release Ocular Drug Delivery Systems Market Share by Application in 2020 & 2026
Figure 6. Cataract Examples
Figure 7. Glaucoma Examples
Figure 8. Corneal Transplantation Examples
Figure 9. Others Examples
Figure 10. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) Growth Rate (2015-2026)
Figure 11. Global Sustained Release Ocular Drug Delivery Systems Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Sustained Release Ocular Drug Delivery Systems Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 13. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) Growth Rate (2015-2026)
Figure 17. Europe Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Sustained Release Ocular Drug Delivery Systems Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Sustained Release Ocular Drug Delivery Systems Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Sustained Release Ocular Drug Delivery Systems Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Sustained Release Ocular Drug Delivery Systems Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Sustained Release Ocular Drug Delivery Systems Players Market Share by Revenue in Sustained Release Ocular Drug Delivery Systems 2015 & 2019
Figure 28. Sustained Release Ocular Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Type (2015-2020)
Figure 30. Global Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Application (2015-2020)
Figure 32. Global Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type in 2019
Figure 34. United States Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type in 2019
Figure 35. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share by Company in 2019
Figure 36. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type in 2019
Figure 37. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application in 2019
Figure 38. China Sustained Release Ocular Drug Delivery Systems Sales Market Share by Company in 2019
Figure 39. China Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type in 2019
Figure 40. China Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application in 2019
Figure 41. Japan Sustained Release Ocular Drug Delivery Systems Sales Market Share by Company in 2019
Figure 42. Japan Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type in 2019
Figure 43. Japan Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application in 2019
Figure 44. Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales Market Share by Company in 2019
Figure 45. Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type in 2019
Figure 46. Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application in 2019
Figure 47. India Sustained Release Ocular Drug Delivery Systems Sales Market Share by Company in 2019
Figure 48. India Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type in 2019
Figure 49. India Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Sustained Release Ocular Drug Delivery Systems
Figure 52. Manufacturing Process Analysis of Sustained Release Ocular Drug Delivery Systems
Figure 53. Sustained Release Ocular Drug Delivery Systems Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
眼用ドラッグデリバリーの世界市場レポート2020 Market Analysis and Insights: Global Ocular Drug Delivery Market The global Ocular Drug Delivery market size is projected to reach US$ 33610 million by 2026, from US$ 25430 million in 2020, at a CAGR of 4.8% during 2021-2026. Global Ocular Drug Delivery Scope and Market Size The global Ocular Drug D…- 肺用ドラッグデリバリーシステムの世界市場レポート2020 Pulmonary drug delivery systems are used to the treatment of various respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD), delivering locally acting drugs directly to their site of action. Advantages of pulmonary drug delivery systems over oral drugs is the excellent cap…
- ドラッグデリバリースマートピルの世界市場レポート2020 Market Analysis and Insights: Global Drug-delivery Smart Pill Market The global Drug-delivery Smart Pill market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Drug-delivery Smart Pill Scope and Market Size The global Drug-del…
- 注射・注入ベースドラッグデリバリーデバイスの世界市場レポート2020 Market Analysis and Insights: Global Injection And Infusion-based Drug Delivery Devices Market The global Injection And Infusion-based Drug Delivery Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Injection And …
- 鼻腔内ドラッグデリバリーデバイスの世界市場レポート2020 Market Analysis and Insights: Global Intranasal Drug Delivery Device Market The global Intranasal Drug Delivery Device market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Intranasal Drug Delivery Device Scope and Market Siz…